Erasca, Inc. (ERAS)
Pharmaceutical Preparations
Latest Price
$18.15
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
1.29
P/B Ratio
14.04
Institutional Ownership
87.9% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 24.68M | $399.0M | 7.94% | +1.95M | 2026-03-31 |
| T. Rowe Price Investment Management, Inc. | 21.26M | $343.0M | 6.84% | +16.47M | 2026-03-31 |
| BlackRock, Inc. | 20.15M | $326.0M | 6.48% | +4.55M | 2026-03-31 |
| VR ADVISER, LLC | 16.38M | $265.0M | 5.27% | -1.47M | 2026-03-31 |
| RTW INVESTMENTS, LP | 16.16M | $261.0M | 5.20% | +16.01M | 2026-03-31 |
| Vivo Capital, LLC | 12.15M | $196.0M | 3.91% | +2.88M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 11.25M | $182.0M | 3.62% | -- | 2026-03-31 |
| Siren, L.L.C. | 11.24M | $181.0M | 3.62% | +2.49M | 2026-03-31 |
| Logos Global Management LP | 11.15M | $180.0M | 3.59% | -1.85M | 2026-03-31 |
| Paradigm Biocapital Advisors LP | 10.39M | $168.0M | 3.34% | -3.77M | 2026-03-31 |